Achieve life sciences, inc. (ACHV)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
COLLABORATION REVENUE [note 3]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,799

15,824

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

COLLABORATION REVENUE (note 3)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

30,067

35,126

36,537

29,882

31,058

27,766

23,855

20,095

11,551

6,155

5,613

5,496

9,141

9,668

0

0

0

EXPENSES
Research and development

7,160

9,674

9,992

9,709

8,722

5,868

5,940

5,224

4,241

3,101

-11,852

-8,895

-4,295

286

-1,655

2,866

4,749

3,780

28,373

29,656

32,994

46,224

49,567

57,985

61,365

55,317

57,767

52,658

45,721

39,948

31,780

22,699

21,782

21,553

20,799

20,064

0

0

0

General and administrative

6,785

6,854

7,036

6,896

7,017

6,945

6,945

6,742

5,084

3,531

-3,307

-2,993

-611

1,428

1,562

2,823

3,415

3,814

11,623

10,957

10,566

10,625

10,338

10,352

10,149

9,892

9,488

8,980

8,554

7,791

7,480

6,972

6,396

6,230

5,566

5,584

0

0

0

Restructuring costs (recovery) [note 8]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Recovery of lease termination loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Litigation settlement [note 7]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring gain [note 7]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Total operating expenses

13,945

16,528

17,028

16,605

15,739

12,813

12,885

11,966

9,325

6,632

-15,676

-13,686

-5,337

1,714

424

7,487

8,595

0

0

0

-

-

-

0

0

-

65,598

59,981

52,618

46,082

63,562

43,431

28,178

27,783

6,101

15,926

0

0

0

Total operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

OTHER INCOME (EXPENSE)
LOSS FROM OPERATIONS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Interest income

150

170

226

247

223

171

97

0

0

-

0

-

-

-

190

161

113

119

107

86

77

35

45

75

110

150

189

242

294

292

279

242

214

220

193

158

0

0

0

Other expenses

-

-

-

0

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Bargain purchase gain [note 2]

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent value rights recovery [note 2]

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on warrants

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-2,485

-1,995

-2,099

-1,897

-1,140

-3,883

-4,927

-3,741

-3,102

-767

-1,053

-3,208

-4,811

-6,580

-7,323

-4,459

-889

-7,161

-3,830

-7,388

0

0

0

-

-

Loss on disposition of intangible asset [note 5]

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expenses

0

-

0

-

0

-

0

-

-

-35

-26

-18

-42

-24

-15

-30

-2

-51

-66

-63

-60

-19

-14

-14

26

120

266

253

211

138

-22

-60

33

6

49

104

0

0

0

Total other income (expense)

134

133

190

200

170

126

96

-6,983

-7,002

-7,002

-7,961

-261

-757

-24

1,163

629

713

468

1,181

3,375

4,413

3,226

2,602

828

1,189

3,478

5,266

7,075

7,828

4,889

18,316

7,379

4,077

7,614

-7,907

667

0

0

0

Net loss before income taxes

-

-

-

-

-

-

-

-

-

-13,634

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7,879

-6,255

0

0

0

Recovery of deferred income taxes [note 5]

-

-

-

-

-

-

-

-

-

-3,051

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax recovery [note 10]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,000

0

0

-

0

Net loss

-13,811

-16,395

-16,838

-16,405

-15,569

-12,687

-12,790

-16,022

-13,400

-10,583

6,209

8,991

2,268

-1,234

-4,554

-5,414

-4,535

-5,345

-20,759

-21,116

-22,121

-26,240

-27,236

-32,383

-33,788

-31,849

-29,274

-25,140

-20,935

-21,098

-30,683

-29,233

-18,488

-14,673

-7,879

-3,255

0

0

0

Net unrealized gain on foreign exchange

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net unrealized gain on securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

13

11

10

5

-4

-7

-21

-3

25

11

6

41

0

0

-

0

-

-

-

-

-

-

-

-

Total other comprehensive income (loss)

-

-

-

-

-

-

-

-

-

-

-

0

-

4

5

17

15

14

5

-4

-7

-21

-3

25

11

6

0

0

0

-

-

-

-

-

0

0

-

-

-

Unrealized gain on cash equivalents and marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Net unrealized loss on securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

Total other comprehensive (loss) income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Comprehensive loss

-13,811

-16,395

-16,838

-16,405

-15,569

-12,687

-12,789

-16,021

-13,400

-10,583

6,201

8,976

2,258

-1,230

-4,549

-5,397

-4,520

-5,331

-20,754

-21,120

-22,128

-26,261

-27,239

-32,358

-33,777

-31,843

-29,284

-25,136

-20,935

-21,097

-30,788

-29,302

-18,484

-14,642

0

0

0

-

-

Basic and diluted net loss per common share

-0.11

-0.16

-0.45

-0.50

-0.88

1.35

-0.71

-1.82

-2.43

75.21

-8.96

-78.66

-9.66

-580.78

-0.12

-0.23

-0.12

-38.58

-0.16

-0.26

-0.20

-0.16

-0.23

-0.47

-0.59

-0.46

-0.68

-0.57

-0.46

-0.20

-0.40

-0.29

-0.67

-

-

0.67

0.31

-

-0.02

Weighted average shares used in computation of basic and diluted net loss per common share

30,936

10,974

8,100

7,189

6,721

6,734

4,533

1,529

1,243

1,171

722

2

21

-89,766

30,013

29,932

29,827

-51,960

28,538

23,484

22,656

21,606

21,079

14,987

14,721

14,708

14,690

14,673

14,660

-

14,619

-

-

-

-

-

-

-

-

Weighted average number of common shares [note 5]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,554

10,235

-

-

9,718

9,713

-

-

Basic loss (income) per common share [note 5(c)]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.46

-

-

1.07

-

Diluted loss (income) per common share [note 5(c)]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.45

-

-

1.07

-

Weighted average number of basic common shares [note 5(c)]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,736

-

-

6,453

6,400

Weighted average number of diluted common shares [note 5(c)]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,043

-

-

6,453

6,529